On February 8, 2022, Denovicon Therapeutics Founder & CEO, Scott Bembenek talked (along with BIOVIA’s Guy Oshiro) at SLAS 2022 about how AI and the use of virtual–real cycles is revolutionizing the drug discovery process.
858-692-3573
info@denovicontx.com
